Black Health
Statin Hyperlipidemia CV prevention

Simvastatin (Zocor) and Black patients

Brand names: Zocor

Last reviewed: Sources checked:

What Simvastatin does

Simvastatin is a moderate-intensity statin that was among the first approved and was long the default generic. It has more drug-drug interactions than atorvastatin or rosuvastatin (heavy CYP3A4 metabolism) and cannot be used at 80 mg due to FDA safety restrictions.

What the evidence says for Black patients

Simvastatin's outcome data comes principally from 4S (Lancet 1994;344:1383–9) and HPS (Lancet 2002;360:7–22) — trials with few Black participants. Extrapolation across race is considered reasonable based on the CTT Collaboration meta-analyses (Lancet 2005, 2010, 2012) which pooled individual-patient data across 170,000+ participants and found consistent LDL dose-response.

A practical caveat for Black patients on antihypertensive regimens: simvastatin interacts with amlodipine — the FDA limits co-prescription to 20 mg simvastatin with amlodipine. Because amlodipine is preferred first-line for hypertension in Black adults, this interaction restricts simvastatin's utility specifically in this population. Switching to atorvastatin or rosuvastatin (which don't have the same interaction) is often simpler.

Common alternatives

Atorvastatin and rosuvastatin have fewer interactions and are usually preferred for patients on CYP3A4 substrates. Pravastatin has the fewest interactions of any statin.

Side effects

  • Myalgia
  • Rare rhabdomyolysis — especially at 80 mg or with interacting drugs
  • Small diabetes risk
  • GI upset

Factors that affect adherence

Simvastatin must be taken in the evening because hepatic cholesterol synthesis peaks at night. Generic simvastatin is inexpensive. Patients on amlodipine should not take simvastatin above 20 mg.

Questions to ask your doctor

Bring this list to your next appointment.

  • If I'm on amlodipine, am I on a simvastatin dose below 20 mg?
  • Would atorvastatin be a better choice for me given my other meds?
  • Should I take this in the evening?

References

  1. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease (4S). Lancet. 1994;344:1383–1389.
  2. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals. Lancet. 2002;360:7–22.
  3. Cholesterol Treatment Trialists (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol. Lancet. 2010;376:1670–1681.
  4. U.S. Food and Drug Administration. Zocor (simvastatin) label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019766s091lbl.pdf

Medical disclaimer

This page is patient education, not prescribing guidance. It summarizes the published evidence about how this medication has been studied in Black patients — it is not a substitute for the judgment of your personal clinician. Never start, stop, or change a prescription based on something you read here. If you have questions about your medication, call your prescriber or pharmacist. For emergencies, call 911.

Read our editorial standards for how we source, review, and update these pages.